First clinical study to assess the effect of the BP1.4979 on BED in female patients over an 8 week-tretament period.
This pilot study is to assess the efficacy and safety of BP1.4979 15 mg BID in female patients with moderate to severe binge eating disorder (BED), as defined according to DSM-5 guidelines.